Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag?

Major healthcare plan provider UnitedHealth Group Incorporated (UNH) is currently viewed as expensive, with the stock trading at a 16.61X forward 12-month Price/Earnings (P/E), which is at a premium compared with the Zacks Medical – HMOs industry average of 14.47X. This valuation generally reflects the market’s strong confidence in the company's future prospects. UnitedHealth has a Value Score of B at present.However, it is important to closely evaluate whether this elevated price is justified based on its ...